For more information or confidential assistance
Call 800-306-3180

Records Reveal Risperdal Side Effects Were Concealed

Risperdal Lawsuit
Recently, internal documents were released that strongly suggested Johnson & Johnson, the manufacturer of Risperdal, concealed evidence that linked the drug to serious side effects. These Risperdal side effects became evident in a clinical trial dubbed RIS 232. The internal documents, which were released by... Read More

Enforcement Sought in Risperdal Settlement Agreement

Risperdal Lawsuit
Dozens of plaintiffs who had filed a Risperdal gynecomastia lawsuit against Johnson & Johnson had reached settlement agreements on January 28, 2013. However, it recently came to light that the drug maker is allegedly trying to back out of the already agreed-upon settlement deal. Attorneys... Read More

J&J to Pay $2.2 Billion Risperdal Settlement

Zimmer Durom Cup Lawsuit
As reported by Bloomberg News and the U.S. Department of Justice, Johnson & Johnson and its subsidiaries will pay $2 billion to resolve both civil and criminal charges over misbranding of its drugs Risperdal, Invega and Natrecor for uses that were not FDA approved. The... Read More

Rispderal Induced Gynecomastia Sparks Litigation

Risperdal Lawsuit
Risperdal received FDA approval in 1993. It is an atypical antipsychotic medication used to treat schizophrenia and symptoms of bipolar disorder, in addition to symptoms of irritability in autistic children. Some doctors have also prescribed it to treat obsessive-compulsive disorder, stuttering, Tourettes syndrome, and severe... Read More